(Reuters) -GSK forecast 2021 earnings at the better end of its guidance range on Wednesday, buoyed by a recovery in routine visits to doctors and…
Home »
Drugmaker GSK plans $550 million expansion of England R&D facility
FILE PHOTO: A GlaxoSmithKline (GSK) logo is seen at the GSK research centre in Stevenage, Britain November 26, 2019. REUTERS/Peter Nicholls/File Photo(Reuters) -Britain’s GlaxoSmithKline on…
GSK rejects Elliott proposal to sell consumer unit, change board
Slideshow ( 2 images )(Reuters) -GSK’s board on Friday rejected Elliott’s demands that the British company change its management and sell its consumer healthcare arm…
GSK fires former U.S. govt vaccine head Slaoui over harassment allegation
Slideshow ( 2 images )FRANKFURT (Reuters) – GlaxoSmithKline has dismissed Moncef Slaoui, former U.S. government vaccine chief, as chairman of a company controlled by the…
Vir, GSK's COVID-19 antibody trial shows 85% drop in hospitalization or death
FILE PHOTO: Company logo of pharmaceutical company GlaxoSmithKline is seen at their Stevenage facility, Britain October 26, 2020. REUTERS/Matthew Childs/File Photo(Reuters) – Interim data from…
GSK sees lower profit this year, split plans on track
FILE PHOTO: Company logo of pharmaceutical company GlaxoSmithKline is seen at their Stevenage facility, Britain October 26, 2020. REUTERS/Matthew Childs/File Photo (Reuters) -Britain’s GSK forecast…
Drug firms GSK and Sanofi in Covid vaccine trial
Drug companies GSK and Sanofi have said they are starting clinical trials of their coronavirus vaccine. The two firms said 440 adults would be given…
GSK, partner Vir join race to find COVID-19 antibody treatment
(Reuters) – GlaxoSmithKline and partner Vir Biotechnology have started testing their experimental antibody on early-stage COVID-19 patients, entering the race to find a winner in…